19 June 2013
Keywords: positive, hf, data, roche, eucardic, latest, analyses
Article | 08 September 2003
The latest analyses of the COMET (Carvedilol or Metoprolol European Trial) study have shown further significant benefits for chronic heart
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
8 September 2003
15 September 2003
© 2013 thepharmaletter.com